Anosmia News and Research

RSS

Triple combination symptoms anosmia-fatigue-cough more specific to COVID-19 than single symptoms

In a research paper published in the journal PLOS ONE, the authors developed COVID–Online, a symptom checking application in Germany.

25 Nov 2021

What is the global prevalence of long COVID?

This study aims to provide a comprehensive synthesis of information on the prevalence and symptoms of PASC.

18 Nov 2021

Phantosmia, parosmia, and dysgeusia in COVID-19 patients

A team of researchers investigated qualitative aspects of olfactory and gustatory symptoms such as phantosmia, parosmia, and dysgeusia and their possible co-relation with the adaptive immune system.

17 Nov 2021

COVID-19 and loss of sense of smell

A recent review examines the high susceptibility of the olfactory epithelium to SARS-CoV-2 infection.

9 Nov 2021

Brain fog in long COVID

A new study explores one troubling manifestation of long COVID, which is the cognitive impairment that follows clinical resolution of COVID-19.

26 Oct 2021

SARS-CoV-2 anti-nucleocapsid antibodies reduce risk of reinfection for at least eight months

A new study concludes that at least with predominantly wild-type variants, the risk of reinfection with the virus among unvaccinated people is reduced by 80% or more.

22 Oct 2021

New method to diagnose anosmia

In a recent study, researchers discuss a new method of tracking the Nav1.7 channel to reduce the reliance on more invasive diagnostic measures.

13 Oct 2021

Taste loss as a COVID-19 symptom: a review

A new review reports that alterations in taste affected about a third of individuals with a COVID-19 diagnosis, with females being affected more than males.

12 Oct 2021

The neurological effects of COVID-19

What is the relationship between COVID-19 and the brain? A new review published in Tropical Biomedicine summarizes the key findings on how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes severe COVID-19 infection, disrupts brain activity and produces a range of long-term neurological disorders.

10 Oct 2021

Ground-breaking research reveals wider impact of altered sensing on people’s daily lives

Ground-breaking research conducted by research experts with AbScent’s Long Covid online group has recorded for the first time the wider impact of altered sensing on people’s daily lives.

4 Oct 2021

Long-term effects of COVID-19 in children

A recent preprint deals with the incidence and importance of long COVID in children.

23 Sep 2021

Pediatric SARS-CoV-2 infections usually mild, says study

A new study in the journal BMC Pediatrics describes the clinical phenotypes and outcomes in a thousand children who developed COVID-19.

16 Sep 2021

Activated mast cell disorders potentially linked to SARS-CoV-2 immunity

An intriguing new study reports a year-long study in patients with cMCADs from all over France.

7 Sep 2021

Hypopituitarism and COVID-19 – exploring a possible bidirectional relationship?

In a recent study published in Reviews in Endocrine and Metabolic Disorders, the researchers discuss the extra-pulmonary manifestations of COVID-19.

5 Sep 2021

Smell abnormalities more common among long-COVID Patients

A new study investigates the rising prevalence of abnormalities in the sense of smell persisting in COVID-19 patients.

3 Sep 2021

Double vaccination reduces the risk of Long COVID by almost half

Adults who have received a double vaccination are 49% less likely to have Long COVID should they contract a COVID-19 infection.

2 Sep 2021

Have SARS-CoV-2 symptoms changed in the UK population over time?

A new paper compares changes in the symptoms due to COVID-19 over the course of the pandemic.

29 Aug 2021

Predictability of single symptom screening for pediatric SARS-CoV-2 infections

A new study on the preprint server medRxiv* discusses the predictive value of single symptom-based screening to confirm pediatric SARS-CoV-2 cases.

25 Aug 2021

Increased chemosensory dysfunction with D614G mutation of SARS-CoV-2

A study, available on the pre-print server medRxiv, has determined the underlying molecular mechanisms of how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), especially the G614 strain, leads to olfactory dysfunction causing anosmia.

18 Aug 2021

Study examines asymptomatic, presymptomatic and symptomatic transmission dynamics of SARS-CoV-2

A new preprint, available on the medRxiv* server, describes how researchers found at least a third of infected individuals to be asymptomatic, but that a fifth of them successfully passed on the virus to others. In comparison, about a quarter of symptomatic cases did so, especially when the symptoms included fever, cough and shortness of breath. In these circumstances, up to 30% of them transmitted the virus.

13 Jul 2021